BETNOVATE 0.1% SCALP APPLICATION 30ML

Indications

Approved Uses

Steroid-responsive inflammatory dermatoses of the scalp (e.g., scalp psoriasis, seborrhoeic dermatitis/seborrhoeic capitis, and other corticosteroid-responsive eczematous/inflammatory scalp conditions).

Off-Label Uses

Alopecia areata (scalp) is an off-label use sometimes employed when intralesional therapy is not suitable, though evidence is variable.

Dosage & Administration

Dosing by Condition

For steroid-responsive scalp dermatoses (including scalp psoriasis and seborrhoeic dermatitis): apply a small amount to affected areas once or twice daily initially; reduce to once daily or less frequently as soon as control is achieved and stop when resolved; reassess if not improving within ~2 weeks.

Initial Dose

Apply a few drops (approximately 1 ml) to affected scalp areas twice daily

Maintenance Dose

Once daily or alternate days, using the minimum amount to maintain control

Maximum Dose

No fixed maximum volume is established for this scalp solution; limit to the smallest amount needed to cover affected scalp and avoid prolonged continuous use-generally reassess if not improved within 2-4 weeks (earlier in children).

Children's Dosage

Not recommended in children under 1 year; in children over 1 year, use with extreme caution, for the shortest duration possible, and avoid occlusion - maximum 30 ml per week

Dose Adjustment Notes

Use the minimum effective amount for the shortest duration; avoid occlusion and large surface-area use (increases systemic absorption); use extra caution in children/elderly and in hepatic impairment if significant absorption is possible; taper frequency once controlled to reduce relapse and adverse effects.

How to Take

Part the hair to expose the affected area; apply a small amount (a few drops) of the 0.1% scalp solution to the dry scalp and gently rub/massage in; allow to dry and avoid washing the hair immediately after application; wash hands after use; avoid contact with eyes/face and broken skin; the solution is alcohol-based and flammable-avoid smoking or open flames during and shortly after application.

Side Effects

Common Side Effects

Application-site burning/stinging, pruritus, irritation/dryness; with prolonged or extensive use: skin atrophy/thinning, telangiectasia/striae, folliculitis, and secondary infection.

Side Effect Frequency

Common: local burning/stinging/pain, pruritus, irritation/dryness. Uncommon: folliculitis, acneiform eruptions, contact dermatitis, hypopigmentation, hypertrichosis, skin atrophy, striae, telangiectasia. Rare/very rare: secondary infection, allergic sensitization, and systemic effects (HPA-axis suppression/Cushingoid features), especially with prolonged use, large areas, or occlusion.

Safety & Warnings

Warnings & Precautions

Flammable (keep away from flames); avoid eye contact/face and broken skin; avoid prolonged continuous use and large areas/occlusion (higher systemic absorption, especially in children); do not use on infected scalp without appropriate antimicrobial therapy; taper after prolonged use; caution in psoriasis; advise reporting visual disturbances.

Age Restriction

Avoid use in infants <1 year unless specifically prescribed by a specialist; generally not recommended/contraindicated for dermatoses in children under 1 year.

Driving Warning

Safe

Drug Interactions

Food Interaction

No restriction

Special Populations

Pregnancy

Caution

Children

Not recommended in children under 1 year; in children over 1 year, use with extreme caution, for the shortest duration possible, and avoid occlusion - maximum 30 ml per week

Elderly

Standard adult dosing. The minimum quantity should be used for the shortest duration to achieve the desired clinical benefit.

Liver Impairment

No routine dose adjustment for topical use; in severe hepatic impairment or when treating large areas/prolonged courses, use the minimum effective amount for the shortest duration and monitor for systemic effects.

Storage & Patient Advice

Stopping the Medicine

Do not stop abruptly after prolonged/large-area use-taper by reducing frequency/potency under medical supervision to reduce rebound/withdrawal.

Overdose

Acute topical overdose is unlikely; excessive/prolonged use can cause HPA-axis suppression and Cushingoid features-manage by gradual withdrawal and supportive monitoring; accidental ingestion warrants medical assessment and supportive care.

Patient Counseling

Apply a small amount (a few drops) to the affected scalp areas only and gently massage in; use exactly as prescribed and for the shortest duration needed. For external use only-avoid contact with eyes, face, and broken skin; if it gets in the eyes, rinse well with water. Wash hands after application (unless treating the hands). Do not use under occlusion (e.g., tight dressings, shower cap) unless specifically directed. This scalp solution is flammable-keep away from heat/open flames and do not smoke until it has dried. Stop and seek medical advice if irritation, signs of infection, or worsening occurs; if not improving within ~2-4 weeks, review with the prescriber. If used for a prolonged period, taper as directed to reduce rebound flare.

Monitoring Requirements

Monitor response and local adverse effects (atrophy, telangiectasia/striae, folliculitis, irritation) and assess for secondary infection; with prolonged/high-dose use or large areas/occlusion (especially in children): monitor for HPA-axis suppression; in psoriasis, supervise for rebound/instability and avoid abrupt overuse.

Pharmacology

Mechanism of Action

Betamethasone valerate is a potent topical glucocorticoid that binds intracellular glucocorticoid receptors to modulate gene transcription, decreasing pro-inflammatory mediators and immune cell activity and producing anti-inflammatory, antipruritic, and vasoconstrictive effects in skin.

Onset of Action

Symptomatic improvement (itch/erythema) often begins within a few days, with clearer clinical improvement typically within 1-2 weeks; reassess if no meaningful response by ~2 weeks.

Duration of Effect

Clinical benefit is maintained only while treatment continues; relapse is common after discontinuation in chronic relapsing conditions (e.g., psoriasis, seborrhoeic dermatitis).

Bioavailability

Systemic bioavailability after topical scalp use is generally low, but percutaneous absorption increases with inflammation/skin barrier disruption, prolonged or large-area use, higher potency, and occlusion; absorption is also higher on thinner skin than on thicker areas.

Excretion

Absorbed corticosteroid is metabolized and excreted mainly via the kidneys as metabolites (conjugated forms), with some biliary/fecal excretion possible.

Product Information

Available Dosage Forms

For this SFDA-registered product: scalp solution (scalp application). Other betamethasone valerate products may exist as cream/ointment/lotion depending on market, but they are not the dosage form of this specific SFDA record.

Composition per Dose

Each ml of scalp application: 1 mg betamethasone as betamethasone valerate (0.1% w/v) in an isopropyl alcohol-based vehicle

Skin Condition

Psoriasis, Eczema, Seborrheic Dermatitis

Steroid Potency

Potent

Legal Disclaimer - Al Mujtama Pharmacy

The product information provided is derived from verified pharmaceutical references and is intended for general health education only. It is not a substitute for professional medical advice, diagnosis, or treatment.

Al Mujtama Pharmacy assumes no legal or medical liability for:

• Any therapeutic decision made based on the information displayed without consulting a licensed physician or pharmacist
• Any discrepancy between the information provided and the product's package insert or SFDA guidelines
• Any misuse of medication resulting from personal interpretation of the content displayed

Important notice: Drug formulations and instructions may vary between production batches. Always rely on the leaflet included inside the product packaging you have, and consult your pharmacist or physician before starting, adjusting, or discontinuing any medication.

By using this content, you acknowledge that you have read this disclaimer and agree that Al Mujtama Pharmacy bears no liability arising from reliance on this information as a substitute for direct medical consultation.

Your health is a trust - always consult your doctor first.